Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Juan Pablo Alderuccio
Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma
British Journal of Haematology
Hematology
Related publications
Real World Data on Rituximab Maintenance Therapy After Frontline Immunochemotherapy in Grade 1-3a Follicular Lymphoma
British Journal of Haematology
Hematology
Chronic Hepatitis E in Patients With Indolent Lymphoma After Treatment With Rituximab and Bendamustine
Hepatology
Medicine
Hepatology
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Annals of Hematology
Medicine
Hematology
Maintenance Rituximab Is Associated With Improved Overall Survival in Mantle Cell Lymphoma Patients Responding to Induction Therapy With Bendamustine + Rituximab (Br)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Follicular Non-Hodgkin Lymphoma
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Adult Atypical Sporadic Burkitt Lymphoma Successfully Treated With Bendamustine and Rituximab
Lymphoma and Chronic Lymphocytic Leukemias
CONSOLIDATION THERAPY USING 90 Y-Ibritumomab TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB FOR RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRiZ2012)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Rituximab Alone (R) Versus Rituximab Plus Bendamustine (Br) for Splenic (Smzl) and Nodal Marginal Zone Lymphoma (Nmzl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Bendamustine and Rituximab in Elderly Patients With Low-Tumour Burden Follicular Lymphoma. Results of the LYSA Phase II BRIEF Study
British Journal of Haematology
Hematology
